| P50 | author | Bruce A. Mueller | Q37370971 |
| P2093 | author name string | Brian J Donovan | |
| | Kenneth C Lamp | |
| | Jason A Crompton | |
| | Sara Yankalev | |
| P2860 | cites work | Cubicin Outcomes Registry and Experience (CORE) methodology | Q43923385 |
| | High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity | Q45302930 |
| | Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. | Q46766488 |
| | Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. | Q51785920 |
| | Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells | Q24682375 |
| | Daptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditis | Q33576260 |
| | Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. | Q34155402 |
| | The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections | Q34330270 |
| | Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus | Q34558111 |
| | Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 |
| | Hemodialysis complications | Q36163641 |
| | The pharmacokinetic and pharmacodynamic properties of vancomycin | Q36328971 |
| | Population pharmacokinetics of daptomycin | Q36670451 |
| | Drug dosing considerations in alternative hemodialysis. | Q36866256 |
| | Infections in patients with chronic kidney disease | Q36934703 |
| | Staphylococcus aureus bloodstream infections: the association between age and mortality and functional status | Q37228768 |
| | Intradialytic administration of daptomycin in end stage renal disease patients on hemodialysis | Q37258898 |
| | Burden of infection in patients with end-stage renal disease requiring long-term dialysis | Q38444972 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 665-672 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Pharmacotherapy | Q7180800 |
| P1476 | title | Safety of daptomycin in patients receiving hemodialysis. | |
| P478 | volume | 31 | |